Leaderboards/Pancreatitis Pathology and Treatment

Pancreatitis Pathology and Treatment

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Alessandro Mannucci
Vita-Salute San Raffaele University
2
Lotte Boxhoorn
Amsterdam University Medical Centers
3
Xiangjing Cao
Hefei University of Technology
4
Mohamad Hizami Mohamad Nor
National University of Malaysia
5
Lucía Guilabert
Hospital General Universitario de Alicante Doctor Balmis
6
Yuqiu Han
First Affiliated Hospital Zhejiang University
7
Matteo Regolo
University of Catania
8
Anke Onnekink
Leiden University Medical Center
9
Wuming Liu
First Affiliated Hospital of Xi'an Jiaotong University
10
Xiaowu Dong
Yangzhou University

Papers

1
Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and its fibrotic complication
Nature Communications|2024
80 cit.
2
Publication in The American Journal of Gastroenterology (2024) [61 citations, W4394578524]
The American Journal of Gastroenterology|2024
61 cit.
3
Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future
CA A Cancer Journal for Clinicians|2025
15 cit.
4
Publication in Gut (2024) [14 citations, W4403295819]
Gut|2024
14 cit.
5
Prediction of long-term recurrence-free and overall survival in early-onset colorectal cancer: the ENCORE multi-centre study
npj Precision Oncology|2025
5 cit.
6
Publication in Familial Cancer (2024) [4 citations, W4399260451]
Familial Cancer|2024
4 cit.
7
Publication in Skeletal Muscle (2024) [4 citations, W4404970043]
Skeletal Muscle|2024
4 cit.
8
An Exosome-Based Liquid Biopsy for the Detection of Early-Onset Colorectal Cancer: The ENCODER Multicenter Study
Gastroenterology|2025
4 cit.
9
Circulating Tumor DNA–Based Blood Test for Colorectal Cancer Screening
JAMA|2025
2 cit.
10
Publication in Pancreatology (2024) [1 citation, W4405612640]
Pancreatology|2024
1 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Costas A. Lyssiotis
University of Michigan
2
Yue Zeng
Shanghai Chest Hospital
3
Yue Zeng
Affiliated Hospital of Southwest Medical University
4
Jing Xue
Zhejiang University
5
Szilárd Gódi
Heim Pál Országos Gyermekgyógyászati Intézet
6
Balázs Kui
University of Szeged
7
Barnabás Bod
Magyar Agrár- és Élettudományi Egyetem
8
János Novák
Békés Megyei Központi Kórház
9
Gengwen Huang
Xiangya Hospital Central South University
10
Patrícia Sarlós
Semmelweis University

Papers

1
Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer
Cancer Cell|2024
198 cit.
2
Uridine-derived ribose fuels glucose-restricted pancreatic cancer
Nature|2023
149 cit.
3
Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context
eLife|2022
120 cit.
4
OXPHOS promotes apoptotic resistance and cellular persistence in T <sub>H</sub> 17 cells in the periphery and tumor microenvironment
Science Immunology|2022
108 cit.
5
Intestinal TLR4 deletion exacerbates acute pancreatitis through gut microbiota dysbiosis and Paneth cells deficiency
Gut Microbes|2022
101 cit.
6
EASY‐APP: An artificial intelligence model and application for early and easy prediction of severity in acute pancreatitis
Clinical and Translational Medicine|2022
97 cit.
7
Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells
Nature Cancer|2022
74 cit.
8
Ketogenesis acts as an endogenous protective programme to restrain inflammatory macrophage activation during acute pancreatitis
EBioMedicine|2022
53 cit.
9
Multiomic characterization of pancreatic cancer-associated macrophage polarization reveals deregulated metabolic programs driven by the GM-CSF–PI3K pathway
eLife|2022
53 cit.
10
Tumor Cell‐Intrinsic SETD2 Deficiency Reprograms Neutrophils to Foster Immune Escape in Pancreatic Tumorigenesis
Advanced Science|2022
52 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Santhi Swaroop Vege
Mayo Clinic
2
Hein G. Gooszen
Cal Humanities
3
David C. Whitcomb
Christian Medical College & Hospital
4
Tooru Shimosegawa
Japan Pancreatic Disease Research Foundation
5
David A. Tuveson
Cold Spring Harbor Laboratory
6
Peter A. Banks
Harvard University
7
Miklós Sahin‐Tóth
University of California, Los Angeles
8
Markus W. Büchler
Heidelberg University
9
Andrew L. Warshaw
Harvard University
10
Andrew V. Biankin
University of Glasgow

Papers

1
Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus
Gut|2012
7k cit.
2
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Science|2009
3.1k cit.
3
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
Cancer Cell|2005
2.6k cit.
4
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Cancer Cell|2003
2.5k cit.
5
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
The Journal of Experimental Medicine|2017
2.5k cit.
6
American College of Gastroenterology Guideline: Management of Acute Pancreatitis
The American Journal of Gastroenterology|2013
2.3k cit.
7
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
Nature|2011
2.2k cit.
8
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
Cell|2014
2.2k cit.
9
Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts
Cancer Discovery|2019
2.1k cit.
10
Practice Guidelines in Acute Pancreatitis
The American Journal of Gastroenterology|2006
2.1k cit.

Reagents for Pancreatitis Pathology and Treatment

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 60

IFITM1 Antibody

Cited in 6 papers
#13126$317
View Evidence →
Cell Signaling TechnologyEvidence 60

IL-17F (D3M4D) Rabbit Monoclonal Antibody

Cited in 6 papers
#13186$161,351
View Evidence →
Cell Signaling TechnologyEvidence 64

Phospho-Tyrosine Hydroxylase (Ser31) Antibody

Cited in 5 papers
#3370$362
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 67

Ki-67 (D3B5) Rabbit Monoclonal Antibody (Alexa Fluor® 555 Conjugate)

Cited in 7 papers
#20701$465
View Evidence →
Miltenyi BiotecEvidence 78

MHC MACSimer A*0201 KRAS-G12V (KLVVVGAVGV), human, Vio667

Cited in 7 papers
#130-135-297
View Evidence →
Miltenyi BiotecEvidence 78

MHC MACSimer A*0201 KRAS-G12V (KLVVVGAVGV), human, PE

Cited in 7 papers
#130-136-356
View Evidence →